Emergency / crisis support: /emergency
If a CGRP mAb has been declined, Botox authorisation is stuck, triptans are being limited, or you are having a severe migraine episode that may be an emergency — this guide covers the steps.
Neurological Emergency: When to Seek Emergency Care
Migraine is very rarely a medical emergency, but certain headache presentations require immediate assessment:
- "Thunderclap headache" — sudden-onset, extremely severe headache reaching maximum intensity within seconds to a minute. This is a red-flag symptom requiring emergency CT scan to exclude subarachnoid haemorrhage.
- New neurological deficits — new limb weakness, facial droop, speech disturbance, visual loss. May indicate migraine with prolonged aura or a stroke. Seek emergency care immediately; call an ambulance.
- Status migrainosus — a debilitating migraine lasting more than 72 hours without interruption. Requires IV treatment; emergency care warranted.
- Fever + severe headache + neck stiffness — possible meningitis; emergency care immediately.
For any of these presentations, call an ambulance or proceed to the nearest emergency facility. These are PMB emergencies.
Common Chronic Migraine Financial Crises
- CGRP monoclonal antibody declined — step-therapy not met or documentation inadequate
- Botox exceptional-needs authorisation declined or delayed
- Monthly triptan quantity limit insufficient for attack frequency
- Oral preventive medications hitting MSA limits
- Neurologist consultation shortfall from quarterly Botox visits
If CGRP mAb Was Declined
The most common reasons for CGRP mAb decline and how to address each:
Step-therapy not adequately documented: The scheme requires documented failure of at least two oral preventive agents. "Documented" means written records — not verbal recollection. Ask your neurologist to compile a treatment history: drug, dose, duration, outcome, and reason for discontinuation. Include this explicitly in the application.
Chronic migraine threshold not confirmed: 15+ headache days per month must be supported by data. A headache diary (even reconstructed retrospectively from calendar notes or medication use records) is more compelling than a clinical estimate. If your neurologist has not been using a diary, start one now — confirm baseline before requesting CGRP approval.
Once documentation is complete: Resubmit with the enhanced application. If declined again, request a peer-to-peer review between your neurologist and the scheme's medical advisor. Most CGRP mAb declines are resolved at peer-to-peer or formal appeal stage when properly documented. If still refused, escalate to the CMS.
If Botox Was Declined
Botox (onabotulinumtoxinA, PREEMPT protocol) is a SAHPRA-approved treatment for chronic migraine with strong evidence. A decline should not be accepted without an appeal.
Resubmit with: headache diary confirming 15+ headache days/month, two failed oral preventive trials documented, and the specific PREEMPT protocol (dose 155–195 units, 31 injection sites, every 12 weeks). Reference the relevant international and SA neurology guidelines endorsing Botox for chronic migraine.
Ask the scheme: is this declined on formulary grounds, step-therapy grounds, or clinical evidence grounds? Each requires a different counter-argument.
If Triptans Are Being Over-Limited
If your monthly triptan allowance is inadequate:
- Provide your neurologist with your headache diary data. The scheme may increase the monthly quantity on clinical motivation documenting attack frequency.
- Ask whether the limit is per-product or per-class — if per-product, prescribing a second triptan (e.g., sumatriptan as first-line plus rizatriptan as rescue) may effectively double access.
- Escalating preventive therapy to reduce attack frequency is the sustainable long-term answer — address this with your neurologist alongside the triptan access issue.
If MSA Is Depleted and Oral Preventives Are Needed
Oral migraine preventives are inexpensive. Generic topiramate and amitriptyline cost R100–R400/month. Once MSA is depleted: - Check whether your plan has an ATB - Ask for generic prescriptions if branded versions are prescribed - Valproate is very inexpensive if clinically appropriate for your case
Neurologist Shortfall from Repeated Botox Visits
Three Botox visits per year with a neurologist procedure shortfall of R2,000–R4,000 per visit generates R6,000–R12,000/year in specialist shortfall. If gap cover is in place, submit all invoices for OPL calculation. If not:
Discuss with your neurologist whether consultation and Botox administration fees can be structured to reduce the shortfall gap. Some neurologists will accept scheme rate for the procedure when the patient is on a complex ongoing treatment programme.
Triage Table
| Situation | Priority | Action |
|---|---|---|
| Thunderclap headache / neurological deficit | Emergency | Ambulance; emergency CT |
| Status migrainosus (72+ hours) | High | Emergency IV treatment |
| CGRP mAb declined | High | Document step-therapy; peer-to-peer; appeal |
| Botox declined | High | Resubmit with PREEMPT protocol; appeal |
| Triptan limit insufficient | Medium | Neurologist motivation; second triptan class |
| MSA depleted — preventives needed | Medium | ATB check; generic prescriptions |
Escalation Contacts
Council for Medical Schemes (CMS): 0861 123 267 | www.medicalschemes.org.za Headache South Africa / SA Neurological Association: Through treating neurologist AURA Emergency: /emergency
Talk to Eldon
Get urgent help with your cover situation →
This page is general information about medical schemes. It is not medical advice: speak to a healthcare professional about your own treatment. Medical aid and gap cover advice is given by Eldon de Waal, a Supervised Representative of Approach Administration (FSP 23579).